Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?
Moll G, Hult A, von Bahr L, Alm JJ, Heldring N, Hamad OA, Stenbeck-Funke L, Larsson S, Teramura Y, Roelofs H, Nilsson B, Fibbe WE, Olsson ML, Le Blanc K.
Moll G, et al.
PLoS One. 2014 Jan 13;9(1):e85040. doi: 10.1371/journal.pone.0085040. eCollection 2014.
PLoS One. 2014.
PMID: 24454787
Free PMC article.